Schultz CJ - Search Results

1

Role of radiation therapy in cutaneous melanoma.

Shuff JH, Siker ML, Daly MD, Schultz CJ. Shuff JH, et al. Among authors: schultz cj. Clin Plast Surg. 2010 Jan;37(1):147-60. doi: 10.1016/j.cps.2009.07.007. Clin Plast Surg. 2010. PMID: 19914465 Review.

2

Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases.

Mehta MP, Rodrigus P, Terhaard CH, Rao A, Suh J, Roa W, Souhami L, Bezjak A, Leibenhaut M, Komaki R, Schultz C, Timmerman R, Curran W, Smith J, Phan SC, Miller RA, Renschler MF. Mehta MP, et al. J Clin Oncol. 2003 Jul 1;21(13):2529-36. doi: 10.1200/JCO.2003.12.122. J Clin Oncol. 2003. PMID: 12829672 Clinical Trial.

3

Current management of primary central nervous system lymphoma.

Schultz CJ, Bovi J. Schultz CJ, et al. Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):666-78. doi: 10.1016/j.ijrobp.2009.10.011. Int J Radiat Oncol Biol Phys. 2010. PMID: 20159361 Review.

4

Semicontinuous low-dose-rate teletherapy for the treatment of recurrent glial brain tumors: final report of a phase I/II study.

Siker ML, Firat SY, Mueller W, Krouwer H, Schultz CJ. Siker ML, et al. Among authors: schultz cj. Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):765-72. doi: 10.1016/j.ijrobp.2010.10.057. Epub 2011 Jan 13. Int J Radiat Oncol Biol Phys. 2012. PMID: 21236600 Clinical Trial.

5

Comparing the quality of passively-scattered proton and photon tomotherapy plans for brain and head and neck disease sites.

Kainz K, Firat S, Wilson JF, Schultz C, Siker M, Wang A, Olson D, Li XA. Kainz K, et al. Phys Med Biol. 2015 Mar 21;60(6):2167-77. doi: 10.1088/0031-9155/60/6/2167. Epub 2015 Feb 16. Phys Med Biol. 2015. PMID: 25683607

6

Evaluation of absolute and normalized apparent diffusion coefficient (ADC) values within the post-operative T2/FLAIR volume as adverse prognostic indicators in glioblastoma.

Elson A, Bovi J, Siker M, Schultz C, Paulson E. Elson A, et al. J Neurooncol. 2015 May;122(3):549-58. doi: 10.1007/s11060-015-1743-z. Epub 2015 Feb 21. J Neurooncol. 2015. PMID: 25700835

7

Evaluation of pre-radiotherapy apparent diffusion coefficient (ADC): patterns of recurrence and survival outcomes analysis in patients treated for glioblastoma multiforme.

Elson A, Paulson E, Bovi J, Siker M, Schultz C, Laviolette PS. Elson A, et al. J Neurooncol. 2015 May;123(1):179-88. doi: 10.1007/s11060-015-1782-5. Epub 2015 Apr 17. J Neurooncol. 2015. PMID: 25894597

8

Current Predictive Indices and Nomograms To Enable Personalization of Radiation Therapy for Patients With Secondary Malignant Neoplasms of the Central Nervous System: A Review.

Gilbride L, Siker M, Bovi J, Gore E, Schultz C, Hall WA. Gilbride L, et al. Neurosurgery. 2018 May 1;82(5):595-603. doi: 10.1093/neuros/nyx631. Neurosurgery. 2018. PMID: 29669114 Review.

9

Pulsed Reduced Dose Rate Radiotherapy in Conjunction With Bevacizumab or Bevacizumab Alone in Recurrent High-grade Glioma: Survival Outcomes.

Bovi JA, Prah MA, Retzlaff AA, Schmainda KM, Connelly JM, Rand SD, Marszalkowski CS, Mueller WM, Siker ML, Schultz CJ. Bovi JA, et al. Among authors: schultz cj. Int J Radiat Oncol Biol Phys. 2020 Nov 15;108(4):979-986. doi: 10.1016/j.ijrobp.2020.06.020. Epub 2020 Jun 27. Int J Radiat Oncol Biol Phys. 2020. PMID: 32599030 Free PMC article.

10

Characterization of Underrepresented Populations in Modern Era Clinical Trials Involving Radiation Therapy.

Bero EH, Rein LE, Banerjee A, Straza MW, Lawton CAF, Schultz CJ, Erickson BA, Siker ML, Hall WA. Bero EH, et al. Among authors: schultz cj. Pract Radiat Oncol. 2021 Nov-Dec;11(6):453-459. doi: 10.1016/j.prro.2021.03.012. Pract Radiat Oncol. 2021. PMID: 34742459

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

240 results

Search Page